Latest News about GKOS
Recent news which mentions GKOS
   Earnings Scheduled For July 30, 2025
   
  
  
  July 30, 2025
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For April 30, 2025
   
  
  
  April 30, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
   
  
  
  February 24, 2025
  From Benzinga
 
   Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?
   
  
  
  February 21, 2025
  From Benzinga
 
   Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition
   
  
  
  February 21, 2025
  From Benzinga
 
   Earnings Scheduled For February 20, 2025
   
  
  
  February 20, 2025
  From Benzinga
 From Benzinga
 
   $1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much Today
   
  
  
  January 23, 2025
  From Benzinga
 
   Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
   
  
  
  January 13, 2025
  From Benzinga
 From Benzinga
 
   This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
   
  
  
  December 06, 2024
  From Benzinga
 
   Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
   
  
  
  December 02, 2024
  From Benzinga
 From Benzinga
 
   Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
   
  
  
  November 05, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.